These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 26261508
1. Chinese medicine Tongxinluo reduces atherosclerotic lesion by attenuating oxidative stress and inflammation in microvascular endothelial cells. Wu XL, Zheng B, Jin LS, Zhang RN, He M, Yang Z, Wen JK. Int J Clin Exp Pathol; 2015; 8(6):6323-33. PubMed ID: 26261508 [Abstract] [Full Text] [Related]
2. Chinese medicine Tongxinluo increases tight junction protein levels by inducing KLF5 expression in microvascular endothelial cells. Li LM, Zheng B, Zhang RN, Jin LS, Zheng CY, Wang C, Zhou PP, Guo ZW, Ma D, Wen JK. Cell Biochem Funct; 2015 Jun; 33(4):226-34. PubMed ID: 25907265 [Abstract] [Full Text] [Related]
3. Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction. Wang Y, Kuang X, Yin Y, Han N, Chang L, Wang H, Hou Y, Li H, Li Z, Liu Y, Hao Y, Wei Y, Wang X, Jia Z. Biomed Pharmacother; 2022 Jan; 145():112367. PubMed ID: 34740097 [Abstract] [Full Text] [Related]
4. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip. Ma J, Qiao L, Meng L, Ma L, Zhao Y, Liu X, Ni M, Zhang Y. Biomed Pharmacother; 2019 May; 113():108767. PubMed ID: 30870720 [Abstract] [Full Text] [Related]
5. Tongxinluo inhibits cyclooxygenase-2, inducible nitric oxide synthase, hypoxia-inducible factor-2α/vascular endothelial growth factor to antagonize injury in hypoxia-stimulated cardiac microvascular endothelial cells. Li YN, Wang XJ, Li B, Liu K, Qi JS, Liu BH, Tian Y. Chin Med J (Engl); 2015 Apr 20; 128(8):1114-20. PubMed ID: 25881609 [Abstract] [Full Text] [Related]
7. Tongxinluo (TXL), a Traditional Chinese Medicinal Compound, Improves Endothelial Function After Chronic Hypoxia Both In Vivo and In Vitro. Zheng CY, Song LL, Wen JK, Li LM, Guo ZW, Zhou PP, Wang C, Li YH, Ma D, Zheng B. J Cardiovasc Pharmacol; 2015 Jun 05; 65(6):579-86. PubMed ID: 26065642 [Abstract] [Full Text] [Related]
8. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice. Ma L, Ni M, Hao P, Lu H, Yang X, Xu X, Zhang C, Huang S, Zhao Y, Liu X, Zhang Y. Oncotarget; 2016 Mar 29; 7(13):16194-204. PubMed ID: 26908443 [Abstract] [Full Text] [Related]
9. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition. Yin Y, Zhang Q, Zhao Q, Ding G, Wei C, Chang L, Li H, Bei H, Wang H, Liang J, Jia Z. Biomed Res Int; 2019 Mar 29; 2019():6595437. PubMed ID: 31317035 [Abstract] [Full Text] [Related]
10. Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model. Xiong M, Jia C, Cui J, Wang P, Du X, Yang Q, Zhu Y, Wang W, Zhang T, Chen Y. J Ethnopharmacol; 2015 Jan 15; 159():84-92. PubMed ID: 25449459 [Abstract] [Full Text] [Related]
11. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P. Arterioscler Thromb Vasc Biol; 2007 Dec 15; 27(12):2684-90. PubMed ID: 17916769 [Abstract] [Full Text] [Related]
12. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice. Sun GB, Qin M, Ye JX, Pan RL, Meng XB, Wang M, Luo Y, Li ZY, Wang HW, Sun XB. Toxicol Appl Pharmacol; 2013 Aug 15; 271(1):114-26. PubMed ID: 23639522 [Abstract] [Full Text] [Related]
13. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation. Wang B, Yang Q, Bai WW, Xing YF, Lu XT, Sun YY, Zhao YX. PLoS One; 2014 Aug 15; 9(6):e98047. PubMed ID: 24887083 [Abstract] [Full Text] [Related]
14. Inhibitory effects of oleoylethanolamide (OEA) on H₂O₂-induced human umbilical vein endothelial cell (HUVEC) injury and apolipoprotein E knockout (ApoE-/-) atherosclerotic mice. Ma L, Guo X, Chen W. Int J Clin Exp Pathol; 2015 Aug 15; 8(6):6301-11. PubMed ID: 26261506 [Abstract] [Full Text] [Related]
15. Tongxinluo Reverses the Hypoxia-suppressed Claudin-9 in Cardiac Microvascular Endothelial Cells. Liu K, Wang XJ, Li YN, Li B, Qi JS, Zhang J, Wang Y. Chin Med J (Engl); 2016 Feb 20; 129(4):442-7. PubMed ID: 26879018 [Abstract] [Full Text] [Related]
16. High glucose decreases claudins-5 and -11 in cardiac microvascular endothelial cells: Antagonistic effects of tongxinluo. Li B, Li Y, Liu K, Wang X, Qi J, Wang B, Wang Y. Endocr Res; 2017 Feb 20; 42(1):15-21. PubMed ID: 27111519 [Abstract] [Full Text] [Related]
17. Traditional Chinese medication Tongxinluo attenuates apoptosis in ox-LDL-stimulated macrophages by enhancing Beclin-1-induced autophagy. Chen Y, Li M, Zhang Y, Di M, Chen W, Liu X, Yu F, Wang H, Zhen X, Zhang M. Biochem Biophys Res Commun; 2018 Jun 22; 501(2):336-342. PubMed ID: 29550482 [Abstract] [Full Text] [Related]
18. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M. Hypertens Res; 2006 Jun 22; 29(6):457-66. PubMed ID: 16940709 [Abstract] [Full Text] [Related]
19. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Baumhäkel M, Custodis F, Schlimmer N, Laufs U, Böhm M. Atherosclerosis; 2010 Sep 22; 212(1):55-62. PubMed ID: 20347444 [Abstract] [Full Text] [Related]
20. Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells. Qi K, Yang Y, Geng Y, Cui H, Li X, Jin C, Chen G, Tian X, Meng X. Medicine (Baltimore); 2020 Aug 21; 99(34):e21821. PubMed ID: 32846824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]